Target intelligence / Profile preview

Dengue Virus Type 1 Envelope Protein (None)

Target
None
Molecular classification
Viral protein, Glycoprotein, Fusion protein, Type I membrane protein
01

Overview

The envelope (E) protein of dengue virus type 1 (DENV-1) is the major structural glycoprotein on the surface of the virion. It plays a central role in viral attachment, entry, and membrane fusion during infection. The E protein mediates binding to host cell receptors and undergoes significant conformational changes to facilitate fusion between the viral and host membranes, allowing delivery of the viral genome into the cytosol. The E protein is organized as a homodimer on mature virions and consists of three distinct domains: Domain I (EDI), Domain II (EDII), and Domain III (EDIII). It contains two N-linked glycosylation sites: Asn-67 and Asn-153. EDIII contains epitopes recognized by potent neutralizing antibodies. A hydrophobic pocket at an interdomain interface modulates pH sensitivity required for triggering fusion and represents a potential site for small-molecule inhibitors.

02

Mechanism of action

Inhibition of viral entry by blocking receptor binding or membrane fusion. Stabilization of pre-fusion conformation.

03

Biological functions

Viral attachmentMembrane fusionReceptor bindingEntry into host cellsEliciting immune response
04

Disease associations

InfectionDengue feverDengue hemorrhagic feverDengue shock syndrome
05

Safety considerations

Antibody-dependent enhancement (ADE)Potential for off-target effects on other flaviviruses

Beyond the preview

Go deeper on Dengue Virus Type 1 Envelope Protein (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue Virus Type 1 Envelope Protein (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call